What are the recommended alternatives to ketoconazole for systemic and topical fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 14, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the guidelines for using Ketoconazole (antifungal medication) to treat fungal infections?

What is the treatment for a fungal rash on the pelvis, specifically a cutaneous (skin) fungal infection in the pelvic region?

What is the best course of treatment for a 38-year-old male patient with a demarcated and erythematous rash on his left limb and right foot, suspected to be a fungal infection, and who also experiences excessive sweating?

What is the diagnosis and management for a 9-year-old male presenting with a 3-day history of a pruritic (itchy) skin lesion on his neck that has spread to superficial abrasions with scabs, pus-filled areas, and superficial bleeding sites, unresponsive to antifungal creams?

What is the appropriate management plan for a 46-year-old patient with a fungal infection of the left armpit, nocturia, and a history of thyroid carcinoma, currently on Thyroxine, Losartan, Amlodipine, and Allopurinol, with upcoming endocrinology and radiology appointments?

Should I call poison control for an elevated methemoglobinemia level?

What alternative antibiotic regimens can be used to treat intra‑abdominal infections, particularly in patients with a β‑lactam allergy?

What is the likely cause of persistent spotting three weeks after a miscarriage with low serum beta‑human chorionic gonadotropin (~6 IU/mL) and an endometrial thickness of 8 mm, and what is the next step in management?

What is the appropriate work‑up for a patient presenting with a suspected transient ischemic attack?

What is the role of trans‑arterial chemoembolisation (TACE) combined with immune‑checkpoint inhibitor immunotherapy (e.g., atezolizumab, pembrolizumab, nivolumab) ± bevacizumab in patients with intermediate‑stage hepatocellular carcinoma who have unresectable disease, preserved liver function (Child‑Pugh A or well‑compensated B) and good performance status (ECOG 0‑1)?

What is the recommended dosing regimen and supportive management when using cyproheptadine for moderate‑to‑severe serotonin syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.